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Abstract
Background: Nucleotide 1311 polymorphism at exon 11 of G6PD gene is widely prevalent in
various populations of the world. The aim of the study was to evaluate 1311 polymorphism in
subjects carrying G6PD Mediterranean gene and in general population living in Pakistan.
Results: Patients already known to be G6PD deficient were tested for 563C-T (G6PD
Mediterranean) and 1311 C-T mutation through RFLP based PCR and gene sequencing. A control
group not known to be G6PD deficient was tested for 1311C/T only.
C-T transition at nt 1311 was detected in 60/234 X-chromosomes with 563 C-T mutation (gene
frequency of 0.26) while in 130 of normal 402 X-chromosomes (gene frequency of 0.32).
Conclusion: We conclude that 1311 T is a frequent polymorphism both in general populations
and in subjects with G6PD Mediterranean gene in Pakistan. The prevalence is higher compared to
most of the populations of the world. The present study will help in understanding genetic basis of
G6PD deficiency in Pakistani population and in developing ancestral links of its various ethnic
groups.
Background
Glucose 6-phosphate dehydrogenase (G6PD) deficiency
is one of the most frequent red cell enzymopathies affect-
ing some 400 million people globally[1]. G6PD gene
located on human chromosome Xq28 [2], is associated
with at least 140 distinct disease producing mutations [3].
These mutations are significant in causing hemolysis,
favism, neonatal hyerpbilirubinemia [4]. Besides the dis-
ease producing mutations, numerous silent mutations
unassociated with any conformational change in enzyme
structure have also been demonstrated. Such polymor-
phisms have greatly helped the geneticists for evaluating
clonality of various tumors including uterine myomas [5],
lymphomas [6] and other tumors [7]. Further to it, silent
mutations of G6PD gene have proved to be invaluable
tools in the study of human genome by providing markers
for gene mapping [8]and linkage analysis[9]. There is an
extensive list of G6PD genetic polymorphism that has
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IVS2 NT 9722A-G, IVS11 NT 93 T-C, IVS7 NT 175 C-T and
IVS8 NT 163 C-T [11]. Unfortunately, many of these pol-
ymorphisms had limited utilization as were exclusively
observed in African populations.
Of special interest is the polymorphism seen at 1311
nucleotide of exon 11 of G6PD gene[12]. This is widely
prevalent in multiethnic non African population of the
world and is an important marker in formal genetic anal-
ysis of X-linked loci. The nucleotide produces two alleles
(1311 C and 1311T) that are observed in both G6PD
replete and deficient populations. Polymorphism of 1311
T has been studied extensively in several populations
[12,13]. It does not abolish or create any specific site for
enzyme restriction and therefore can be detected by creat-
ing mismatched antisense primer which produces a site
for BclI digestion when 1311T is present [12].
Pakistan with a population of over 165 million people is
a home to 18 ethnic groups speaking 60 different lan-
guages [14]. The ethnic diversity of this region is attrib-
uted to repeated invasions by Aryans [15], Macedonians
[16], Arabs and Mongols in its long history [17]. Majority
of its people belong to five major ethnic groups: Punjabis,
Sindhis, Pathans, Baluch (Balochis) and Mohajirs [18].
Several distinct ethnic groups exist in each major group
which has generated complex social, cultural and lingual
blend.
The primary objectives were to evaluate NT 1311 poly-
morphism of G6PD gene in various ethnic groups living
in Pakistan and to evaluate its association with 563C-T
mutation in G6PD deficient subjects. The secondary
objective was to compare the results of 1311 polymor-
phism with that reported from other populations of the
world.
Methods
The Aga Khan University Hospital Clinical Laboratory
uses brilliant cresyl blue dye test (Trinity biotech plc,
Wicklow, Ireland) for screening individuals with G6PD
deficiency. Subjects reported as G6PD deficient from Jan-
uary 2006 to December 2008 were identified using a com-
puterized institutional database search utilizing
International Classification of Disease (v9, American
Health Information Management Association, AHIMA,
USA). They were contacted via telephone and were
requested for participation in the study.
In addition, a control group consisting of healthy subjects
who visited the hospital for blood donation was included.
These subjects were classified in to various ethnic groups
based on subject's self classification. They were verbally
scanned through an in-house questionnaire to rule out
the possibility of any disorder but were not tested for
G6PD deficiency. As the frequency of consanguineous
marriages is reported as 31.1% to 58.7% from different
places of the country [19,20], some ethnic mix is expected
in our cultural groups.
From each participant, 5 ml of blood was collected in an
EDTA containing tube afterward white blood cells were
separated and stored for DNA extraction according to
manufacturer's instructions.
DNA extraction and PCR/RFLP for screening G6PD 563-T 
and 1311/T mutations
Genomic DNA was isolated from peripheral blood leuco-
cytes by Wizard® Genomic DNA Purification Kit (Wiscon-
sin, USA). PCR/RFLP technique was used for the detection
of G6PD 563C-T and 1311C/T with primers published
elsewhere [21]. Each PCR reaction in 25 μl volume con-
tained 34 mM Tris-HCl pH 8.8, 8.3 mM ammonium sul-
fate, 1.5 mM MgCl2, 0.2 mM of each dNTP, 75 ng of each
primer, 2 U of Taq polymerase (Promega, Wisconsin,
USA) and 200 ng of genomic DNA. After 30 cycles consist-
ing of 1 min at 94°C, 30 sec at 58/62°C (respectively
for1311C/T and 563 C-T) and 40 sec at 72°C, PCR prod-
ucts were digested overnight at 37°C with either MboII or
BclI restriction enzymes. The digested products were sub-
sequently analyzed electrophorically; MboII produced
277, 119 and 110 bp fragments in G6PD Mediterranean
samples whereas 377 and 119 bp fragments were
observed in normal subjects. DNA samples containing C
at position 1311 showed 23 and 203 bp fragments with
BclI digestion whereas replacement of C by T at this nucle-
otide position resulted in a 180 bp product.
Undigested PCR products were sent to Macrogen® (Seoul,
Korea) for gene sequencing.
The frequency of 1311 polymorphism was evaluated and
compared in two groups; (a) patients carrying G6PD Med-
iterranean gene (b) healthy individuals.
Statistical Analysis
All calculations were computed using statistical package
SPSS version 16.0 (SPSS inc.; Chicago, IL, USA). Pearson's
chi-square test was used for the comparison of statistical
difference between the groups and the threshold of signif-
icance (p-value) was set at 0.05.
Ethical issues
The study was approved by institutional ethical review
committee and informed consent was obtained from all
subjects prior to their enrollment.Page 2 of 7
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Two hundred and seventy four G6PD deficient subjects
including 235 males and 39 females agreed to participate
in the study. Of them 563 C-T mutation was observed in
187 males (79.6%) and in 27 females (69.2%). Thus,
cumulative gene frequency for G6PD Mediterranean was
0.74 in both sexes detected in 234 of 313 X-chromo-
somes. Associated 1311 T allele gene frequency was 60/
234 or 0.26. Gene sequencing was performed on 21 G6PD
deficient DNA samples (three with 1311T and 18 with
1311C) which showed additional 93T/C polymorphism
in intron 11: seven had 93 C and 14 had 93 T. Only two
cases of combined mutations of 1311C-T and 93 T-C were
observed. Both were males and their ages were 4 and 8
days at the time of diagnosis. Their associated G6PD
mutation, if any remained undetected. RFLP-PCR results
for 563 C-T and 1311 C/T are shown in figures 1 &2 and
demographics and gender based results are detailed in
Table 1.
The X-chromosomes of 400 unrelated subjects belonging
to five major and 11 minor ethnicities were analyzed for
1311C/T polymorphism of G6PD gene. All except two
were males with age ranging from 17 to 52 years (median
± SD 27.0 ± 7.0). G6PD levels of the participants were not
performed. It was assumed based on clinical history that
the enrolled subjects were not suffering from G6PD defi-
ciency. Moreover, frequency of G6PD deficiency noted in
general population of the country is 1.8–8.6% [22-30].
There fore, it was expected that the results would not be
skewed even if deficient samples were included in the
study. The distribution of 1311 T with respect to various
ethnicities in Pakistan is summarized in Table 2 which
demonstrated striking similarities among various ethnic
groups living in Pakistan. It was observed that the poly-
morphism was frequent with an incidence of 0.28–0.38 in
five main ethnic groups. Highest prevalence was observed
in Saraiki subjects with a frequency of 0.5. In contrast, no
polymorphism was observed in local Hindu population.
No significant statistical differences were assessed in 1311
T polymorphism in compared groups: Pathans and Jews
(p-value 0.29), Mohajirs and Indians (p-value 0.32) and
Baluchis and Iranians (p-value 0.71).
Discussion
We performed an extensive analysis of 1311 C/T polymor-
phism of G6PD gene within normal Pakistani population
and in subjects with G6PD deficiency. It was found that
this polymorphism is quite frequent in normal and indi-
viduals with G6PD Mediterranean gene. The work ena-
bled us to understand the genetic basis of G6PD
deficiency in Pakistani population and to compare T allele
frequency with various world populations including those
that are considered traditionally to be origin or source of
various ethnic groups residing in Pakistan.
Pakistan is a multilingual and multiethnic nation. Its var-
ious ethnic groups are unequally distributed through out
the country. Punjabis and Pathans which are mainly
located in the North Pakistan constitute 60% and 13% of
the population respectively [31] while Sindhis and Balu-
chis occupy Southern Pakistan. There is considerable eth-
nic admixture among Punjabis because most of the
incoming invaders in the past 2000 years passed through
Punjab and mixed with previous settlers. In contrast,
Pathans are claimed to be descendants of European sol-
diers who accompanied Alexander the Great [32] and are
also considered to be the lost tribe of Jews [33]. Sindhis
and Baluchis that are main occupants of Southern Paki-
stan comprise respectively of 13 and 8% of Pakistani pop-
ulation[34,35]. While former have mixed ethnic
background, the Baluchis are believed to have originated
in Aleppo (Syria) who migrated via Iran to this land [35].
Mohajirs constitute some 8% of population and are a
group of people who migrated to Pakistan from near east
– the present day India after its independence as a separate
state in 1947 [35]. They lack the tribal based ethnic iden-
tity in contrast to the rest of Pakistanis.
Polymorphism of 1311C/T with and without 563C-T 
mutation in Pakistani G6PD deficient population
C-T transition at NT 1311 was detected in 60/234 X-chro-
mosomes carrying G6PD Mediterranean gene (equaling a
gene frequency of 0.26). The frequency of this polymor-
phism was not statistically different for patients whose
DNA did not manifest G6PD 563C-T as was detected in
11/72 X-chromosomes (0.15 gene frequency; p-value
0.189). A lower incidence of 0.13 was observed by Saha et
Table 1: Analysis of X-chromosomes from G6PD deficient subjects with 563 C-T mutation (n = 214).







Males 187 16.8 ± 16.6 187(0.79) 48(0.26) 0.988
Females 27 8.2 ± 12.7 47** (0.60) 12(0.25)
Total 214 9.3 ± 13.4 234(0.74) 60(0.26)
* % of T allele is calculated in association with 563 C-T mutations only
** There were 20 homozygous and 7 heterozygous in this population groupPage 3 of 7
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G6PD Mediterranean in Pakistan[21].
Association of 1311 C/T and 93 T/C polymorphisms
Recently, 1311 C/T polymorphism was observed in asso-
ciation with another silent mutation 93 T/C at intron 11
in South East Asians [36,37]and Chinese populations
[38,39]. The association of two is significant in reducing
G6PD enzyme activity and hence has clinical implications
[39]. Unfortunately, gene sequencing results were availa-
ble for limited number of G6PD deficient patients in the
present study which showed a gene frequency of 0.66 for
combined mutations of 1311C-T and 93 T-C.
G6PD NT1311 Polymorphism in various ethnicities in 
Pakistan
G6PD NT 1311 C-T was observed uniformly in various
ethnic groups in Pakistan with an overall frequency of
0.32. Different results seen in local Hindu and Sariki pop-
ulations may be secondary to small sample size demand-
ing further evaluation. A lower though not statistically
significant frequency for T allele (0.20) was observed by
Saha N et al in 1994 for Pashtoons and Punjabi popula-
tion [21] in contrast to 0.3 in the present work for the
same population (p-value 0.133).
Comparison of NT 1311 polymorphism with global data
Global distribution of the silent mutation within normal
population is summarized in Table 3. The reported fre-
quency of 1311T is surprisingly high (0.45) among Asian
Indians compared to other populations of the world [12].
Central and South America, Jews, Sicilians and Africans
had considerably low gene frequency for this silent muta-
tion ranging from 0.1 to 0.25 [12]. Beutler and Kuhl in
1990 reported frequency of 0.05 for the same in Orientals
[12]. Recently the haplotype is recognized with increasing
frequency in Chinese population [38,40] but the same is
not true for Burmese and Mons [36]. Variable frequencies
have been reported from Bahrain [41] Saudi Arabia [13]
and Iran [42] as 0.30, 0.14 and 0.22 respectively. Similar
Results of RFLP-PCR with Mbo- II digestion in G6PD deficient subjectsFig re 1
Results of RFLP-PCR with Mbo- II digestion in G6PD deficient subjects. Lane 1: 100 bp size marker; lanes: 5, 9–13, 
15–20: 563C-T mutation.
Results of RFLP-PCR with Bcl-I digestion in G6PD deficient individualsFig re 2
Results of RFLP-PCR with Bcl-I digestion in G6PD deficient individuals. Lane 1:100 bp size marker; lane2, 7: 1311T 
polymorphism.Page 4 of 7
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frequency of 0.137 for this polymorphism [42]. We found
that haplotype1311T is prevalent extensively in our vari-
ous ethnic groups with the overall frequency of 0.32 in
general population.
Assessment of 1311 polymorphism with Source Population
Qamar R et al in 2002 through their extensive work on Y-
chromosomal DNA supported origin of Parsis in Iran,
Hazaras from Genghis Khan's army and Negroid Makrani
in Africa [43]. However, they denied the Syrian, Tibetan,
Greek or Jewish origin for Baluch, Balti and Pathan popu-
lation respectively. Subsequent work revealed limited
Greek contribution to Pakistani Pathan Population [32].
Our work was limited in investigating a single allele which
by no means allows us to compare the populations. Also,
statistical comparison between two unrelated studies can
not be conclusive. However, it was interesting to note that
Pathans and Jews, Mohajir and Indians and Baluch and
Irani revealed insignificant statistical differences in 1311 T
frequency. Other groups like Punjabis and Sindhis were
not compared with any population because of their 'mix'
origin.
In this study, we report the presence of silent mutation in
normal G6PD alleles in a frequency of 0.32 which apart
from Asian Indians [12] is highest reported from any pop-
ulation.
Conclusion
We conclude that G6PD nucleotide 1311 T polymor-
phism is relatively common in Pakistani population both
with and without G6PD Mediterranean. It is expected that
the work will help in understanding genetic basis of G6PD
Table 2: Demographic details and gene frequency for 1311 C/T polymorphism of healthy subjects with respect to their ethnicity (n = 
400, M: 398, F: 2)




Mohajir* 68(17.0) 69 50(0.72) 19(0.28)
Pathan 61(15.3) 61 38(0.62) 23(0.38)
Punjabi 60(15.1) 60 41(0.68) 19(0.32)
Baloch 60(15.1) 60 44(0.73) 16(0.27)
Sindhi 60(15.1) 60 37(0.62) 23(0.38)
Gilgiti 17(4.3) 17 11(0.65) 6(0.29)
Sariki 14(3.5) 14 7(0.50) 7(0.50)
Gujrati* 11(2.8) 12 8(0.66) 4 (0.33)
Bhori 9(2.3) 9 6(0.67) 3(0.33)
Hindu 7(1.8) 7 7(1.00) 0(0.00)
Parsi 4(1.0) 4 3((0.75) 1(0.25)
Bangali 1(0.3) 1 0(0.00) 1(1.00)
Burhani 1(0.3) 1 0(0.00) 1(1.00)
Kashmiri 1(0.3) 1 0(0.00) 1(1.00)
Total 400(100) 402 272(0.67) 130(0.32)
* One female subject each in respective ethnic group
Table 3: Global Distribution of T allele gene in various populations
Population No of X-chromosomes studied 1311 T gene frequency Reference
African 20 0.25 [12]
White Jewish 41 0.220 [12]
White Non-Jewish 68 0.132 [12]
Sicilian 18 0.167 [12]
English (Caucasians) 436 0.137 [42]
Central/South American 30 0.100 [12]
Indian 20 0.45 [12]
Chinese 23 0.34 [40]
Burmese 17 0.05 [36]
Mons 19 0.00 [36]
Saudi Arabian 14 0.143 [13]
Iranian 100 0.22 [42]
Bahraini 117 0.30 [41]
Pakistani 402 0.32 Present studyPage 5 of 7
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tral links between various ethnicities residing in this
region.
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